Given the continuous exposure of pulmonary cells to numerous environmental triggers, the aim of the present study was to investigate the potential of GRP78 as a biomarker in a cohort of patients comprising COPD, asthma and interstitial lung disease (ILD). Here, HSPA5 is linked to interstitial lung disease.